Asthma Clinical Trial
Official title:
Effects of Regular Exercise on Physical Fitness, Asthma Control and Quality of Life of Adult Asthmatics
Verified date | May 2017 |
Source | University of Oulu |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to assess the effects of regular exercise on physical fitness, asthma control, and quality of life among adult asthmatics.
Status | Completed |
Enrollment | 131 |
Est. completion date | June 30, 2015 |
Est. primary completion date | June 30, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years to 65 Years |
Eligibility |
Inclusion Criteria: - diagnosis of asthma made by physician, or reimbursement for asthma medication from the National Social Insurance Institution of Finland (code 203), or patient fulfills the diagnostic criteria for asthma as outlined in the Finnish Guidelines for Asthma Management (Käypä hoito -suositus 2006 and 2012) Exclusion Criteria: - FEV1 < 60 % of predicted in spirometry - PEF variability > 30 % at least 2 times during a 1-week monitoring period - use of bronchodilating medication at least 4 times daily - permanent, daily steroid tablet treatment - patients who exercise regularly already at baseline at least 3 times a week at least 30 min at a time - serious coronary heart disease - severe hypotension - severe heart failure - severe musculoskeletal disorder - dementia - physician-diagnosed chronic obstructive lung disease |
Country | Name | City | State |
---|---|---|---|
Finland | Center for Environmental and Respiratory Health Research, University of Oulu | Oulu |
Lead Sponsor | Collaborator |
---|---|
University of Oulu | Foundation of the Finnish Anti-Tuberculosis Association, GlaxoSmithKline, Ida Montin Foundation, Jalmari and Rauha Ahokas Foundation, Oulu University Hospital, Research Foundation of the Pulmonary Diseases, Vaino and Laina Kivi Foundation |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Lung function | Lung function measured with spirometry | Baseline and 6 months | |
Other | Quality of Life | Quality of life assessed using St. Georges Respiratory Questionnaire | Baseline and 6 months | |
Other | Step test | Indirect maximal oxygen consumption test using with 6 min step-walk-test | Baseline and 6 months | |
Other | Muscle strength and flexibility | Muscle strength and flexibility tests | Baseline and 6 months | |
Primary | Asthma control | Asthma control based on symptom score and PEF-values | 6-month period | |
Secondary | Physical fitness | Physical fitness measured with spiroergometry | Baseline and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|